2024-11-19 10:39:05
SDIC leads the investment of Xuanzhu Biopharmaceutical with RMB 800 million, promoting innovation and R&D
Corporate/ 2023-07-23
SDIC leads the investment of Xuanzhu Bio...

HONG KONG,Aug. 24,2020-- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "Sihuan Pharmaceutical" or the "Company",...

Adlai Nortye Announces First Patient Dosed in Phase 1b Clinical Trial of AN0025 (EP4 Antagonist) in Combination with Merck's KEYTRUDA® (pembrolizumab) for Advanced Solid Tumors
Health/ 2023-07-22
Adlai Nortye Announces First Patient Dos...

NORTH BRUNSWICK,N.J.,Aug. 24,2020-- Adlai Nortye Ltd. ("Adlai Nortye"),a global clinical-stage biopharmaceutical company today ann...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release